½ÃÀ庸°í¼­
»óǰÄÚµå
1609579

ÇコÄÉ¾î ½ÃÇè, °Ë»ç ¹× ÀÎÁõ ¾Æ¿ô¼Ò½Ì ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ¼­ºñ½ºº°, À¯Çüº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Healthcare Testing, Inspection And Certification Outsourcing Market Size, Share, & Trends Analysis Report By Service (Testing, Inspection), By Type (Medical Devices, Pharmaceutical), By Region, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 140 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÇコÄÉ¾î ½ÃÇè, °Ë»ç ¹× ÀÎÁõ ¾Æ¿ô¼Ò½Ì ½ÃÀå ¼ºÀå°ú µ¿Çâ

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ¼¼°è ÇコÄÉ¾î ½ÃÇè, °Ë»ç ¹× ÀÎÁõ ¾Æ¿ô¼Ò½Ì ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 97¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025-2030³â ¿¬Æò±Õ 8.89%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ÀÇ·á±â±â ¹× ÀǾàǰÀÇ ¾ÈÀü Ç¥ÁØÀ» Çâ»ó½ÃŰ´Â µ¥ µµ¿òÀÌ µÇ°í, Á¦Ç°ÀÇ ¾ÈÀü¼ºÀ» È®ÀÎÇϱâ À§ÇØ Á¤ºÎ°¡ ¾ö°ÝÇÑ ±ÔÁ¦¸¦ °­È­Çϰí ÀÖÀ¸¸ç, ½ÃÇè, °Ë»ç ¹× ÀÎÁõ(TIC) ¼­ºñ½ºÀÇ Ã·´Ü ±â¼ú »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù.

COVID-19´Â ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ÀÇ·á °Ë»ç ¹× ÀÎÁõ ±â¾÷Àº Äڷγª ¹ÙÀÌ·¯½º¿¡ ´ëÀÀÇÏ´Â µ¥ »ç¿ëµÇ´Â ¾ÈÀüÇÏ°í ½Å¼ÓÇϸç È¿À²ÀûÀÎ Á¦Ç°À» Á¦°øÇϱâ À§ÇØ Çù·ÂÇÏ¿© °¡°ÝÀ» ³·Ãß°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á±â±â´Â ÀÇ·á¿ë TIC ½ÃÀå¿¡ ¸¹Àº ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2020³â 10¿ù, CSA´Â ij³ª´Ù¿¡¼­ COVID-19 ´ëÀÀ¿¡ »ç¿ëµÇ´Â PPE ŰƮ¿¡ ´ëÇÑ ½ÃÇè, °Ë»ç ¹× ÀÎÁõÀ» ¹ßÇ¥ÇÏ¿´½À´Ï´Ù.

ÀÇ·á TIC ¼­ºñ½º Á¦°ø¾÷üµéÀº »ê¾÷À» º¯È­½ÃŰ´Â ½Å±â¼úÀÇ ÀáÀç·ÂÀ» Ȱ¿ëÇϰí Àü¹® ¾÷ü¿Í ÆÄÆ®³Ê½ÊÀ» ¸Î´Â °æ¿ì°¡ ¸¹±â ¶§¹®¿¡ ¼³ºñ ÅõÀÚ´Â ´õ¿í Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÅÈï±¹ÀÇ Áß»êÃþ Áõ°¡, ¾ÈÀü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÀÎÇÁ¶ó ÁöÃâ Áõ°¡°¡ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 12¿ù SGS SA´Â ¹ÙÀÌ¿ÀÀǾàǰ ºÐ¼® °Ë»ç ¿ª·®À» È®´ëÇϱâ À§ÇØ ÀǾàǰ ¿¬±¸ °³¹ß ±â°üÀÎ Quay Pharma¸¦ ÀμöÇß½À´Ï´Ù.

ÇコÄÉ¾î ½ÃÇè, °Ë»ç ¹× ÀÎÁõ ¾Æ¿ô¼Ò½Ì ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • ¼­ºñ½º ºÎ¹®Àº ½ÃÇè, °Ë»ç ¹× ÀÎÁõ ¼­ºñ½º·Î ±¸ºÐµÇ¸ç, 2024³â ½ÃÀå Á¡À¯À²Àº °Ë»ç ¼­ºñ½º°¡ 63.80%·Î °¡Àå Å« ºñÁßÀ» Â÷ÁöÇß½À´Ï´Ù.
  • ÀÇ·á±â±â´Â ¿¹Ãø ±â°£ µ¿¾È 8.48%ÀÇ CAGR·Î °¡Àå ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ÀÇ·á±â±â Á¦Á¶¾÷üµéÀÌ ÇÙ½É ¿ª·®¿¡ ÁýÁßÇϰí TIC ½Ã¼³À» ¾Æ¿ô¼Ò½ÌÇϰí Àֱ⠶§¹®ÀÔ´Ï´Ù.
  • 2024³â À¯·´ÀÌ 43.50%ÀÇ ÃÖ´ë ¸ÅÃâ Á¡À¯À²·Î ¼¼°è ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÇコÄÉ¾î ½ÃÇè, °Ë»ç ¹× ÀÎÁõ ¾Æ¿ô¼Ò½Ì ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • »óºÎ ½ÃÀå Àü¸Á
    • °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ±â¼ú »óȲ
  • °¡°Ý ¸ðµ¨ ºÐ¼®
  • ½ÃÀå ºÐ¼® Åø
    • Porter's Five Forces ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå ÇコÄÉ¾î ½ÃÇè, °Ë»ç ¹× ÀÎÁõ ¾Æ¿ô¼Ò½Ì ½ÃÀå : ¼­ºñ½ºº°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼­ºñ½º º¯µ¿ ºÐ¼®
  • ¼­ºñ½ºº°, 2018-2030³â
  • ½ÃÇè
  • °Ë»ç
  • ÀÎÁõ

Á¦5Àå ÇコÄÉ¾î ½ÃÇè, °Ë»ç ¹× ÀÎÁõ ¾Æ¿ô¼Ò½Ì ½ÃÀå : À¯Çüº°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • À¯Çü º¯µ¿ ºÐ¼®
  • À¯Çüº°, 2018-2030³â
  • ÀÇ·á±â±â
  • Á¦¾à

Á¦6Àå ÇコÄÉ¾î ½ÃÇè, °Ë»ç ¹× ÀÎÁõ ¾Æ¿ô¼Ò½Ì ½ÃÀå : Áö¿ªº°, ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â°ú 2030³â
  • Áö¿ªº° ½ÃÀå ´ë½Ãº¸µå
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • µ§¸¶Å©
    • ½º¿þµ§
    • ³ë¸£¿þÀÌ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ű¹
    • Àεµ³×½Ã¾Æ
    • ¸»·¹À̽þÆ
    • ½Ì°¡Æ÷¸£
    • ´ë¸¸
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ
    • Ä¥·¹
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®
    • À̽º¶ó¿¤

Á¦7Àå °æÀï ±¸µµ

  • ±â¾÷ ºÐ·ù
    • ½ÃÀå ¸®´õ
    • ½ÅÈï ÁøÃâ ±â¾÷
  • ±â¾÷ ½ÃÀå »óȲ ºÐ¼®, 2024³â(±â¾÷ È÷Æ®¸Ê ºÐ¼®)
  • ±â¾÷ °³¿ä
    • SGS SA
    • Intertek Group plc
    • Eurofins Scientific SE
    • DEKRA CERTIFICATION BV
    • UL Solutions Inc.
    • TUV SUD
    • ALS Limited
    • CSA Group Testing &Certification Inc.
    • Applus+Technologies, Inc.
    • Element Materials Technology
ksm 25.01.03

Healthcare Testing, Inspection, And Certification Outsourcing Market Growth & Trends:

The global healthcare testing, inspection, and certification outsourcing market size is expected to reach USD 9.71 billion by 2030, expanding at a CAGR of 8.89% from 2025 to 2030, according to a new report by Grand View Research, Inc. The main drivers of this market are that it helps in improving safety standards of medical devices and pharmaceuticals, there is the rise in strict regulations imposed by the government to make sure that the product is safe, and the increasing use of advanced technology for testing, inspection, and certification (TIC) services.

The COVID-19 pandemic significantly impacted the market. The healthcare testing, inspection, and certification companies are collaborating to reduce the prices to provide safe, quick, and efficient products that will be used to fight the coronavirus. Also, medical devices are producing a lot of opportunities for the healthcare TIC market. For instance, in October 2020, CSA announced the testing, inspection, and certification of PPE kits that are used to fight against COVID-19 in Canada.

As healthcare TIC service providers are capitalizing on the promise of new technologies to revolutionize the industry, frequently by forming partnerships with specialized providers, capital investment is expected to rise even more. Market expansion is being aided by the growth of the middle class in emerging nations, a rise in the need for safety, and rising infrastructure spending. For instance, in December 2021, SGS SA acquired Quay Pharma, a pharma R&D organization, to expand its capability in biopharmaceutical analytical testing.

Healthcare Testing, Inspection, And Certification Outsourcing Market Report Highlights:

  • The services segment is segmented into testing, inspection, and certification services. And the testing services accounted for the largest market share of 63.80% in 2024
  • The medical device is anticipated to expand at the fastest CAGR of 8.48% during the forecast period. This is due to medical device companies focusing on their core competencies and getting TIC facilities outsourced
  • Europe dominated the global market with the largest revenue share of 43.50% in 2024, owing to the presence of a large number of players

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Market Analysis Tools
    • 3.5.1. Porter's five forces analysis
    • 3.5.2. PESTEL analysis

Chapter 4. Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market: Service Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Service Movement Analysis
  • 4.3. Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates & Forecasts, by Service, 2018-2030 (USD Million)
  • 4.4. Testing
    • 4.4.1. Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Testing
    • 4.5.1. Inspection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Certification
    • 4.6.1. Certification Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market: Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Type Movement Analysis
  • 5.3. Healthcare Testing, Inspection and Certification Outsourcing: Market Estimates & Forecasts, by Type, 2018-2030 (USD Million)
  • 5.4. Medical Devices
    • 5.4.1. Medical Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Pharmaceutical
    • 5.5.1. Pharmaceutical Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market: Regional Estimates & Trend Analysis

  • 6.1. Regional market share analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. North America
    • 6.3.1. North America Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Landscape
      • 6.3.2.4. U.S. Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Landscape
      • 6.3.3.4. Canada Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Landscape
      • 6.3.4.4. Mexico Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. U.K.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Landscape
      • 6.4.2.4. U.K. Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Landscape
      • 6.4.3.4. Germany Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Landscape
      • 6.4.4.4. France Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Landscape
      • 6.4.5.4. Italy Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Landscape
      • 6.4.6.4. Spain Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Denmark
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Landscape
      • 6.4.7.4. Denmark Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.8. Sweden
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Competitive Scenario
      • 6.4.8.3. Regulatory Landscape
      • 6.4.8.4. Sweden Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Key Country Dynamics
      • 6.4.9.2. Competitive Scenario
      • 6.4.9.3. Regulatory Landscape
      • 6.4.9.4. Norway Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Landscape
      • 6.5.2.4. China Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Japan
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Landscape
      • 6.5.3.4. Japan Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Landscape
      • 6.5.4.4. India Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Landscape
      • 6.5.5.4. South Korea Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Australia
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Landscape
      • 6.5.6.4. Australia Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Thailand
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Landscape
      • 6.5.7.4. Thailand Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Indonesia
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Competitive Scenario
      • 6.5.8.3. Regulatory Landscape
      • 6.5.8.4. Indonesia Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Malaysia
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Competitive Scenario
      • 6.5.9.3. Regulatory Landscape
      • 6.5.9.4. Malaysia Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.10. Singapore
      • 6.5.10.1. Key Country Dynamics
      • 6.5.10.2. Competitive Scenario
      • 6.5.10.3. Regulatory Landscape
      • 6.5.10.4. Singapore Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.11. Taiwan
      • 6.5.11.1. Key Country Dynamics
      • 6.5.11.2. Competitive Scenario
      • 6.5.11.3. Regulatory Landscape
      • 6.5.11.4. Taiwan Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Landscape
      • 6.6.2.4. Brazil Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Landscape
      • 6.6.3.4. Argentina Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. Colombia
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Landscape
      • 6.6.4.4. Colombia Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Chile
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Landscape
      • 6.6.5.4. Chile Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Middle East and Africa
    • 6.7.1. Middle East and Africa Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Landscape
      • 6.7.2.4. South Africa Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Landscape
      • 6.7.3.4. Saudi Arabia Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Landscape
      • 6.7.4.4. UAE Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Landscape
      • 6.7.5.4. Kuwait Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.6. Israel
      • 6.7.6.1. Key Country Dynamics
      • 6.7.6.2. Competitive Scenario
      • 6.7.6.3. Regulatory Landscape
      • 6.7.6.4. Israel Healthcare Testing, Inspection and Certification (TIC) Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
    • 7.1.1. Market Leaders
    • 7.1.2. Emerging Players
  • 7.2. Company Market Position Analysis, 2024 (Company Heat Map Analysis)
  • 7.3. Company Profiles
    • 7.3.1. SGS SA
      • 7.3.1.1. Participant's Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Service Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Intertek Group plc
      • 7.3.2.1. Participant's Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Service Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Eurofins Scientific SE
      • 7.3.3.1. Participant's Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Service Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. DEKRA CERTIFICATION B.V.
      • 7.3.4.1. Participant's Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Service Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. UL Solutions Inc.
      • 7.3.5.1. Participant's Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Service Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. TUV SUD
      • 7.3.6.1. Participant's Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Service Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. ALS Limited
      • 7.3.7.1. Participant's Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Service Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. CSA Group Testing & Certification Inc.
      • 7.3.8.1. Participant's Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Service Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. Applus+ Technologies, Inc.
      • 7.3.9.1. Participant's Overview
      • 7.3.9.2. Financial Performance
      • 7.3.9.3. Service Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. Element Materials Technology
      • 7.3.10.1. Participant's Overview
      • 7.3.10.2. Financial Performance
      • 7.3.10.3. Service Benchmarking
      • 7.3.10.4. Strategic Initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦